Market Tracker

01/23 5:16pm ET

Incyte Corp (NASDAQ:INCY)

117.42
Delayed Data
As of 3:59pm ET
 +0.20 / +0.17%
Today’s Change
55.00
Today|||52-Week Range
122.68
+17.10%
Year-to-Date

Today’s Trading

Previous close117.22
Today’s open118.27
Day’s range116.68 - 119.26
Volume1,752,099
Average volume (3 months)1,424,212
Market cap$22.1B
Dividend yield--
Data as of 3:59pm ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+2,007.55%
Earnings growth (next 5 years)+94.65%
Revenue growth (last year)+47.36%
P/E ratio148.6
Price/Sales26.95
Price/Book127.83

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...+0.03+0.04%
MYLMylan NV-1.04-2.81%
BAXBaxter International...-0.21-0.45%
ZTSZoetis Inc-0.22-0.41%
Data as of 4:01pm ET, 01/23/2017

Financials

Next reporting dateFebruary 16, 2017
EPS forecast (this quarter)$0.13
Annual revenue (last year)$753.8M
Annual profit (last year)$6.5M
Net profit margin0.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts